Why spirulina might matter for the brain
The brain is the most metabolically active tissue in the body and generates disproportionate amounts of free radicals as a byproduct. Neurodegeneration — whether Alzheimer’s, Parkinson’s, or age-related cognitive decline — involves a combination of oxidative stress and neuroinflammation.
Spirulina addresses both of these drivers:
- Phycocyanin is a direct free-radical scavenger that crosses the blood-brain barrier in animal models.
- Anti-inflammatory effects (COX-2 inhibition) reduce prostaglandin-driven neuroinflammation.
- Iron correction — iron deficiency is strongly associated with cognitive impairment, particularly in children and adolescents.
The animal evidence
Alzheimer’s models
Several studies have used spirulina or phycocyanin extract in rodent models of Alzheimer’s disease (typically amyloid-beta induced or APPsw transgenic mice). Results consistently show:
- Reduced amyloid-beta plaque accumulation with spirulina supplementation.
- Improved performance in spatial memory tasks (Morris water maze).
- Reduced neuroinflammatory markers (TNF-α, IL-1β) in brain tissue.
Parachikova et al. (2010) demonstrated that spirulina feeding in aged mice reduced amyloid-beta and improved learning. These findings are interesting mechanistically but animal Alzheimer’s models have a poor translation record to human treatment — most interventions that worked in mice have failed in human trials.
Parkinson’s models
In MPTP-induced Parkinson’s models (neurotoxin that destroys dopaminergic neurons), spirulina extract showed neuroprotective effects — reducing dopaminergic neuron loss and improving motor function. The mechanism: phycocyanin reducing MPTP-induced oxidative stress in the substantia nigra.
Again, this is animal evidence. MPTP models are useful for mechanism research but are not predictive of human treatment response.
The iron-cognition connection
This is the most evidence-based cognitive connection for spirulina. Iron deficiency — even without anaemia — is associated with impaired cognitive function, attention, and memory in children, adolescents, and adults. The mechanism is well-established: iron is required for myelination, dopamine synthesis, and neuronal energy metabolism.
Spirulina’s iron content at 3–5 g/day with vitamin C could contribute to addressing borderline iron deficiency — which in turn could improve cognitive function in people where that deficiency was the bottleneck. This is not the dramatic “brain boost” claimed in marketing; it is a nutritional correction with cognitive consequences.
The blood-brain barrier question
For any dietary compound to have direct neuroprotective effects, it needs to cross the blood-brain barrier. Phycocyanin has been shown to cross the BBB in rodent models. Whether this occurs in humans at the concentrations achieved by oral supplementation at 3–5 g/day is not established.
The indirect pathways (reducing systemic oxidative stress, reducing neuroinflammatory signals that cross the BBB, improving iron status) are more mechanistically accessible than direct phycocyanin entry into brain tissue.
What this means in practice
For adults taking spirulina for other evidence-based reasons: the cognitive benefit is a possible long-term bonus, particularly through iron correction and systemic anti-inflammatory effects. Worth noting but not a primary rationale.
For people specifically interested in cognitive protection: the direct evidence is not there yet. If this area interests you, watch for human trials as the research matures — the mechanistic case is coherent enough that trials are likely in the coming decade.
For established cognitive support at this time, the better-evidenced options are: omega-3 fatty acids (DHA/EPA), Mediterranean diet adherence, physical exercise, and addressing vascular risk factors.